
Intercept Pharmaceuticals ICPT
Intercept Pharmaceuticals EBITDA per Share | ICPT
Annual EBITDA per Share Intercept Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.54 | -0.83 | -6.88 | -9.75 | -9.87 | -13.2 | -16.2 | -9.6 | -5.42 | 0.01 | 0.03 | 0.12 | 0.14 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.14 | -16.2 | -5.54 |
Quarterly EBITDA per Share Intercept Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.1 | -0.17 | -0.76 | - | -0.28 | -0.44 | -0.33 | - | -0.12 | 0.08 | -0.86 | -1.23 | -1.6 | -1.53 | -2.54 | -2.72 | -2.22 | -1.89 | -2.74 | -2.76 | -1.85 | -2.31 | -2.93 | -4.17 | -2.51 | -3.14 | -3.34 | -4.59 | -3.27 | -3.11 | -5.17 | -3.64 | -2.09 | -2.01 | -1.78 | - | 0.01 | 0.01 | - | - | - | - | - | - | 0.01 | 0.02 | 0.02 | - | 0.05 | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.08 | -5.17 | -1.74 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AbbVie
ABBV
|
8.95 | $ 263.04 | 0.49 % | $ 465 B | ||
|
AbCellera Biologics
ABCL
|
-0.67 | $ 11.41 | 2.15 % | $ 3.41 B | ||
|
Фармсинтез
LIFE
|
-0.23 | - | - | - | ||
|
Aclaris Therapeutics
ACRS
|
-0.62 | $ 5.53 | 6.02 % | $ 678 M | ||
|
ADC Therapeutics SA
ADCT
|
-0.95 | $ 1.09 | 3.74 % | $ 139 M | ||
|
Amryt Pharma plc
AMYT
|
-0.16 | - | - | $ 621 M | ||
|
Evelo Biosciences
EVLO
|
-1.22 | - | -14.46 % | $ 27.9 M | ||
|
Allakos
ALLK
|
-1.29 | - | - | $ 28.6 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-2.84 | - | - | $ 231 M | ||
|
Clovis Oncology
CLVS
|
-0.34 | - | -7.23 % | $ 13 M | ||
|
Chimerix
CMRX
|
-1.08 | - | - | $ 756 M | ||
|
Concert Pharmaceuticals
CNCE
|
-2.21 | - | - | $ 401 M | ||
|
ADMA Biologics
ADMA
|
0.84 | $ 8.61 | 0.16 % | $ 2.05 B | ||
|
Eiger BioPharmaceuticals
EIGR
|
-48.4 | - | -9.21 % | $ 2.55 M | ||
|
89bio
ETNB
|
-3.67 | - | - | $ 1.55 B | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
-1.63 | - | - | $ 384 M | ||
|
Fusion Pharmaceuticals
FUSN
|
-1.49 | - | - | $ 1.41 B | ||
|
Guardion Health Sciences
GHSI
|
-3.4 | - | -0.31 % | $ 3.64 M | ||
|
Genocea Biosciences
GNCA
|
-0.74 | - | -15.0 % | $ 3.04 M | ||
|
Gritstone Oncology
GRTS
|
-1.14 | - | 0.42 % | $ 213 M | ||
|
G1 Therapeutics
GTHX
|
-0.75 | - | - | $ 370 M | ||
|
Harpoon Therapeutics
HARP
|
-1.99 | - | - | $ 763 M | ||
|
Humanigen
HGEN
|
-0.77 | - | -81.12 % | $ 4.28 M | ||
|
HOOKIPA Pharma
HOOK
|
-3.88 | - | -6.92 % | $ 79.4 M | ||
|
IGM Biosciences
IGMS
|
-3.3 | - | - | $ 76.9 M | ||
|
IMV
IMV
|
-0.28 | - | - | $ 13.1 M | ||
|
Intra-Cellular Therapies
ITCI
|
-1.13 | - | - | $ 13.6 B | ||
|
Kinnate Biopharma
KNTE
|
-2.58 | - | - | $ 123 M | ||
|
Chinook Therapeutics
KDNY
|
-2.82 | - | - | $ 2.6 B | ||
|
Kaleido Biosciences
KLDO
|
-2.04 | - | -3.69 % | $ 12.4 M | ||
|
Kronos Bio
KRON
|
-1.52 | - | 1.49 % | $ 50.8 M | ||
|
Karuna Therapeutics
KRTX
|
-13.3 | - | - | $ 12.2 B | ||
|
Landos Biopharma
LABP
|
-3.62 | - | 0.58 % | $ 144 M | ||
|
La Jolla Pharmaceutical Company
LJPC
|
0.8 | - | - | $ 154 M | ||
|
LogicBio Therapeutics
LOGC
|
-1.18 | - | - | $ 229 M | ||
|
Lumos Pharma
LUMO
|
-4.49 | - | - | $ 35.3 M | ||
|
Merrimack Pharmaceuticals
MACK
|
-0.14 | - | - | $ 216 M | ||
|
Stealth BioTherapeutics Corp
MITO
|
-0.07 | - | - | $ 23.9 M | ||
|
Mirati Therapeutics
MRTX
|
-13.5 | - | - | $ 3.3 B | ||
|
NexImmune
NEXI
|
-30.4 | - | 70.13 % | $ 4.12 M | ||
|
9 Meters Biopharma
NMTR
|
-3.24 | - | -42.97 % | $ 1.05 M | ||
|
InVivo Therapeutics Holdings Corp.
NVIV
|
-6.89 | - | -37.48 % | $ 476 K | ||
|
Nymox Pharmaceutical Corporation
NYMX
|
-0.05 | - | -19.68 % | $ 18.4 M | ||
|
ObsEva SA
OBSV
|
-1.79 | - | -15.52 % | $ 10.5 M | ||
|
Oncorus
ONCR
|
-2.81 K | - | -8.54 % | $ 3.19 M | ||
|
OncoSec Medical Incorporated
ONCS
|
-0.94 | - | 31.87 % | $ 1.61 M | ||
|
Oncternal Therapeutics
ONCT
|
-14.2 | - | -24.12 % | $ 1.56 M | ||
|
Opiant Pharmaceuticals
OPNT
|
1.18 | - | - | $ 109 M | ||
|
Orchard Therapeutics plc
ORTX
|
-0.97 | - | 1.02 % | $ 90.8 M |